
Hernia Mesh Devices Market
Description
Hernia Mesh Devices Market
Growth Factors of Hernia Mesh Devices Market
The hernia mesh devices market size was valued at USD 2.19 billion in 2023, and the market is now projected to grow from USD 2.29 billion in 2024 to USD 3.76 billion by 2032, exhibiting a CAGR of 6.4% during the forecast period of 2024-2032.
During the pandemic, the worldwide hernia mesh gadgets market fell in value. Non-emergency approaches have been postponed to avoid clinic overcrowding and virus transmission. Lower product demand and supply chain disruption brought about sales declines for marketplace players.
Hernia prevalence is increasing globally, with 38.8% of individuals experiencing it. This is better in overweight or obese individuals. Hernia repair surgical procedures also are growing, with a 120,000 in the UK and 1.0 million within the US annually. Abdominal hernia surgeries account for 15%-18% of world surgeries. Most hernia methods use hernia mesh devices, with 8.0% of surgeries using those gadgets. This increase in hernia surgical treatment call for is fueling the worldwide hernia mesh devices market growth.
Hernias have become more not unusual, main to extended call for hernia mesh. Market participants are prioritizing technical developments in their goods to meet growing demand.
Comprehensive Analysis of Hernia Mesh Devices Market
The marketplace for hernia mesh gadgets is segmented into biological mesh and artificial mesh. Biological mesh, which includes Phasix, is anticipated to grow at a massive CAGR due to its mechanical strength and reduced recurrence charge for incisional hernia. Synthetic mesh, however, is expected to develop at a large CAGR due to its value-effectiveness and decrease hazard of adverse occasions. The market is in addition divided into inguinal, femoral, ventral, and others. The inguinal segment is expected to grow at a substantial CAGR due to the high number of inguinal hernia repairs performed. The end-user segment is dominated by hospitals and acute care centers (ASCs), with hospitals performing around 100,000 hernia repair surgeries annually and 3 out of every four using mesh. The specialty clinics segment is also expected to grow at a significant CAGR due to increasing awareness of the efficiency of mesh procedures.
The North America region lead the hernia mesh devices market share by benefitting a market size of USD 0.77 billion in 2023 due to increased awareness and the presence of major companies including Baxter, B. Braun SE, and Medtronic.
In 2023, Medtronic, BD, and COOK held a vast international hernia mesh devices market share due to their attention on mergers and acquisitions. Medtronic teamed with virtual healthcare carrier issuer La Poste in October 2023 to expand its operations. Other players include Baxter, Integra LifeSciences, and W. L. Gore & Associates, Inc.
In December 2022, W. L. Gore and Associates, Inc. Collaborated with AGC Biologics on protein-based purification technology to reduce the manufacturing footprint and medical manufacturing costs.
Segmentation Table
ATTRIBUTE DETAILS
Study Period 2019-2032
Base Year 2023
Estimated Year 2024
Forecast Period 2024-2032
Historical Period 2019-2022
Growth Rate CAGR of 6.4% from 2024-2032
Unit Value (USD billion)
Segmentation By Product
- Biological Mesh
- Synthetic Mesh
By Type
- Inguinal
- Femoral
- Ventral
- Others
By End-user
- Hospitals & ASCs
- Specialty Clinics
- Others
By Region
- North America (by Product, by Type, by End-user, and by Country)
- U.S.
- Canada
- U.K.
- Germany
- France
- Spain
- Italy
- Scandinavia
- Rest of Europe
- Japan
- China
- Australia
- India
- Southeast Asia
- Rest of Asia Pacific
Please Note: It will take 5-6 business days to complete the report upon order confirmation.
Table of Contents
100 Pages
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
- 4. Key Insights
- 4.1. Prevalence of Hernia Disease – by Key Countries/Sub-region, 2022/2023
- 4.2. New Product Launches – by Key Players
- 4.3. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
- 4.4. Impact of COVID-19 on the Market
- 5. Global Hernia Mesh Devices Market Analysis, Insights and Forecast, 2019-2032
- 5.1. Market Analysis, Insights and Forecast – By Product
- 5.1.1. Biological Mesh
- 5.1.2. Synthetic Mesh
- 5.2. Market Analysis, Insights and Forecast – By Type
- 5.2.1. Inguinal
- 5.2.2. Femoral
- 5.2.3. Ventral
- 5.2.4. Others
- 5.3. Market Analysis, Insights and Forecast – By End-user
- 5.3.1. Hospitals & ASCs
- 5.3.2. Specialty Clinics
- 5.3.3. Others
- 5.4. Market Analysis, Insights and Forecast – By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Rest of the World
- 6. North America Hernia Mesh Devices Market Analysis, Insights and Forecast, 2019-2032
- 6.1. Market Analysis, Insights and Forecast – By Product
- 6.1.1. Biological Mesh
- 6.1.2. Synthetic Mesh
- 6.2. Market Analysis, Insights and Forecast – By Type
- 6.2.1. Inguinal
- 6.2.2. Femoral
- 6.2.3. Ventral
- 6.2.4. Others
- 6.3. Market Analysis, Insights and Forecast – By End-user
- 6.3.1. Hospitals & ASCs
- 6.3.2. Specialty Clinics
- 6.3.3. Others
- 6.4. Market Analysis, Insights and Forecast – By Country
- 6.4.1. U.S.
- 6.4.2. Canada
- 7. Europe Hernia Mesh Devices Market Analysis, Insights and Forecast, 2019-2032
- 7.1. Market Analysis, Insights and Forecast – By Product
- 7.1.1. Biological Mesh
- 7.1.2. Synthetic Mesh
- 7.2. Market Analysis, Insights and Forecast – By Type
- 7.2.1. Inguinal
- 7.2.2. Femoral
- 7.2.3. Ventral
- 7.2.4. Others
- 7.3. Market Analysis, Insights and Forecast – By End-user
- 7.3.1. Hospitals & ASCs
- 7.3.2. Specialty Clinics
- 7.3.3. Others
- 7.4. Market Analysis, Insights and Forecast – By Country/Sub-Region
- 7.4.1. Germany
- 7.4.2. U.K.
- 7.4.3. France
- 7.4.4. Italy
- 7.4.5. Spain
- 7.4.6. Scandinavia
- 7.4.7. Rest of Europe
- 8. Asia Pacific Hernia Mesh Devices Market Analysis, Insights and Forecast, 2019-2032
- 8.1. Market Analysis, Insights and Forecast – By Product
- 8.1.1. Biological Mesh
- 8.1.2. Synthetic Mesh
- 8.2. Market Analysis, Insights and Forecast – By Type
- 8.2.1. Inguinal
- 8.2.2. Femoral
- 8.2.3. Ventral
- 8.2.4. Others
- 8.3. Market Analysis, Insights and Forecast – By End-user
- 8.3.1. Hospitals & ASCs
- 8.3.2. Specialty Clinics
- 8.3.3. Others
- 8.4. Market Analysis, Insights and Forecast – By Country/Sub-Region
- 8.4.1. China
- 8.4.2. Japan
- 8.4.3. India
- 8.4.4. Australia
- 8.4.5. Southeast Asia
- 8.4.6. Rest of Asia Pacific
- 9. Rest of the World Hernia Mesh Devices Market Analysis, Insights and Forecast, 2019-2032
- 9.1. Market Analysis, Insights and Forecast – By Product
- 9.1.1. Biological Mesh
- 9.1.2. Synthetic Mesh
- 9.2. Market Analysis, Insights and Forecast – By Type
- 9.2.1. Inguinal
- 9.2.2. Femoral
- 9.2.3. Ventral
- 9.2.4. Others
- 9.3. Market Analysis, Insights and Forecast – By End-user
- 9.3.1. Hospitals & ASCs
- 9.3.2. Specialty Clinics
- 9.3.3. Others
- 10. Competitive Analysis
- 10.1. Global Market Share Analysis (2023)
- 10.2. Company Profiles
- 10.2.1. Johnson & Johnson, Inc
- 10.2.1.1. Overview
- 10.2.1.2. Products & Services
- 10.2.1.3. SWOT Analysis
- 10.2.1.4. Recent Developments
- 10.2.1.5. Strategies
- 10.2.1.6. Financials (Based on Availability)
- 10.2.2. Medtronic
- 10.2.2.1. Overview
- 10.2.2.2. Products & Services
- 10.2.2.3. SWOT Analysis
- 10.2.2.4. Recent Developments
- 10.2.2.5. Strategies
- 10.2.2.6. Financials (Based on Availability)
- 10.2.3. Unisur Lifecare Pvt. Ltd.
- 10.2.3.1. Overview
- 10.2.3.2. Products & Services
- 10.2.3.3. SWOT Analysis
- 10.2.3.4. Recent Developments
- 10.2.3.5. Strategies
- 10.2.3.6. Financials (Based on Availability)
- 10.2.4. BD
- 10.2.4.1. Overview
- 10.2.4.2. Products & Services
- 10.2.4.3. SWOT Analysis
- 10.2.4.4. Recent Developments
- 10.2.4.5. Strategies
- 10.2.4.6. Financials (Based on Availability)
- 10.2.5. B. Braun SE
- 10.2.5.1. Overview
- 10.2.5.2. Products & Services
- 10.2.5.3. SWOT Analysis
- 10.2.5.4. Recent Developments
- 10.2.5.5. Strategies
- 10.2.5.6. Financials (Based on Availability)
- 10.2.6. W. L. Gore & Associates, Inc.
- 10.2.6.1. Overview
- 10.2.6.2. Products & Services
- 10.2.6.3. SWOT Analysis
- 10.2.6.4. Recent Developments
- 10.2.6.5. Strategies
- 10.2.6.6. Financials (Based on Availability)
- 10.2.7. AbbVie
- 10.2.7.1. Overview
- 10.2.7.2. Products & Services
- 10.2.7.3. SWOT Analysis
- 10.2.7.4. Recent Developments
- 10.2.7.5. Strategies
- 10.2.7.6. Financials (Based on Availability)
- 10.2.8. COOK BIOTECH
- 10.2.8.1. Overview
- 10.2.8.2. Products & Services
- 10.2.8.3. SWOT Analysis
- 10.2.8.4. Recent Developments
- 10.2.8.5. Strategies
- 10.2.8.6. Financials (Based on Availability)
- 10.2.9. Integra LifeSciences
- 10.2.9.1. Overview
- 10.2.9.2. Products & Services
- 10.2.9.3. SWOT Analysis
- 10.2.9.4. Recent Developments
- 10.2.9.5. Strategies
- 10.2.9.6. Financials (Based on Availability)
- 10.2.10. Lap Tech Medical Sdn Bhd
- 10.2.10.1. Overview
- 10.2.10.2. Products & Services
- 10.2.10.3. SWOT Analysis
- 10.2.10.4. Recent Developments
- 10.2.10.5. Strategies
- 10.2.10.6. Financials (Based on Availability)
- 10.2.11. Baxter
- 10.2.11.1. Overview
- 10.2.11.2. Products & Services
- 10.2.11.3. SWOT Analysis
- 10.2.11.4. Recent Developments
- 10.2.11.5. Strategies
- 10.2.11.6. Financials (Based on Availability)
- 10.2.12. Herniamesh S.r.l.
- 10.2.12.1. Overview
- 10.2.12.2. Products & Services
- 10.2.12.3. SWOT Analysis
- 10.2.12.4. Recent Developments
- 10.2.12.5. Strategies
- 10.2.12.6. Financials (Based on Availability)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.